MedPath

A retrospective cohort study on the efficacy and safety of coix seed and its processed products in the treatment of eczema

Phase 2
Recruiting
Conditions
eczema
Registration Number
ITMCTR2023000050
Lead Sponsor
Affiliated Hospital of Jiangxi University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. The diagnosis meets the standards for eczema in the Chinese Clinical Dermatology and Traditional Chinese Medicine Syndrome Diagnosis and Efficacy Standards;
2. No gender limit,Age unlimited;
3.The therapeutic medication contains coix seed or its processed products (Fa coix seed, bran fried coix seed);
4. Have at least one follow-up record.

Exclusion Criteria

1) Pregnant or lactating women;
2) Traditional Chinese patent medicines and simple preparations contains Coix seed.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.